Genesystem

Venture Capital
PORTFOLIO

Industry : DNA Analysis facility and biochip

Investment Year : 2010
Investment Type : Early Stage Financing

Genesystem has sold more than 70 equipment to Korean FDA and lots of primer companies in 2017 and has a plan to go to the technical offering in 2019.

Genesystem has developed the Quick and Real-time portable PCR and long time stable bio-chip, by which DNA verification within 20min is possible. 

The company had won the patent prize from the President of South Korea in 2013. The patents are covering the most compact sized optical design, the Shortest heating/cooing structure, and the most reliable bio-chip. By such patents, the most compact sized quick PCR equipment was developed.

Genesystem has sold more than 70 equipment to Korean FDA and lots of primer companies in 2017 and has a plan to go to the technical offering in 2019.